-
Transcending Generations of Medical Oncologists — From History-making to Making History
Done
-
VISIT TO RESEARCH POSTERDone
-
TEA SYMPOSIUM Advancing Cancer Care Through Biosimilars: Enhancing Access While Maintaining Clinical Confindence
Done
-
From Clinical Evidence to Consultation Room: Optimizing Abemaciclib Therapy in High-Risk Early and Advanced HR+/HER2- Breast Cancer
Done
-
PLENARY SESSION 6.1 Policy, Access, and Equity in Cancer Care
Done
-
WORKSHOP LECTURE 4
Done
-
PSMO FELLOWSHIP NIGHTDone
-
PSMO BUSINESS MEETINGDone
-
GENETIC COUNSELLING TRAINING WORKSHOP (SIMULTANEOUS)
Done
-
BREAKDone
LUNCH SYMPOSIUM Changing the Paradigm: Improving Outcomes of First Line HER2-Positive mBC with Trastuzumab Deruxtecan-based Treatment
10/9/26, 12:45 PM
-
10/9/26, 1:45 PM
(Asia/Manila)
(1 hour)
Speaker: Samuel Ow, MD
Sponsor: AstraZeneca
Sponsor: AstraZeneca